Georgetown University Medical Center
Georgetown University Medical Center
Washington D.C., District of Columbia, United States11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Home-based Vision Rehabilitation Guided by Brain Imaging | Brain Injuries, Traumatic, Craniocerebral Trauma, Hemianopsia, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Quadrantanopsia, Sensation Disorders, Signs and Symptoms, blindness (disorder), brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, cortical blindness, eye disorder, injury, neoplasm, nervous system disorder, nervous system injury, stroke disorder, vascular disorder, vision disorder | Recruiting | Not applicable | 2026-09-14 | NCT07635329 | |
| Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training | Brain Injuries, Traumatic, Craniocerebral Trauma, Hemianopsia, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Quadrantanopsia, Sensation Disorders, Signs and Symptoms, blindness (disorder), brain disorder, brain injury, cardiovascular disorder, central nervous system cancer, central nervous system disorder, cerebrovascular disorder, cortical blindness, eye disorder, injury, neoplasm, nervous system disorder, nervous system injury, stroke disorder, vascular disorder, vision disorder | Recruiting | Not applicable | 2026-09-14 | NCT07105358 | |
| A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Not stated | 2026-08-07 | NCT05568459 | |
| Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors | Select Advanced Solid Tumors | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-06 | NCT04262466 | |
| A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma | Advanced Melanoma | Active, not recruiting | Phase 2 | 2026-01-16 | NCT05529316 | |
| A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, neoplasm, thrombocytosis disease | Active, not recruiting | Phase 2 | 2025-08-13 | NCT05482971 | |
| HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 | 2025-06-22 | NCT04676477 | |
| ReadMap: Reading in Stroke Alexia and Typical Aging | Craniocerebral Trauma, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, alexia, aphasia, apraxia, brain disorder, brain injury, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, dyslexia, injury, language disorder, learning disability, nervous system disorder, nervous system injury, neurodevelopmental disorder, psychiatric disorder, specific learning disability, speech disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2024-11-21 | NCT06700005 | |
| Brain-based Understanding of Individual Language Differences After Stroke | Craniocerebral Trauma, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Disorders, Signs and Symptoms, alexia, aphasia, apraxia, brain disorder, brain injury, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, communication disorder, dyslexia, injury, language disorder, learning disability, nervous system disorder, nervous system injury, neurodevelopmental disorder, psychiatric disorder, specific learning disability, speech disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2024-11-12 | NCT04991519 | |
| The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) | Kidney Transplant Rejection | Active, not recruiting | Not stated | 2024-08-06 | NCT04091984 | |
| A Clinical Trial Comparing the BAGUERA C to the Marketed Mobi-C® for the Treatment of Cervical Disc Disease at 2 Contiguous Levels | nervous system disorder, neuromuscular disease, peripheral nervous system disorder, radiculopathy | Active, not recruiting | Not applicable | 2024-03-08 | NCT04564885 |